Indications and uses
Reduces duration of common cold Reduces severity of cold symptoms: stuffy nose, sneezing, sore throat, coughing, and congestion
Reduces duration of common cold Reduces severity of cold symptoms: stuffy nose, sneezing, sore throat, coughing, and congestion
For Adults and Children 12 years old and older: Note: For maximum benefit, begin treatment at first sign of cold. Completely dissolve entire tablet in mouth. Do not chew. Do not swallow whole. Take one tablet at the onset of symptoms. Repeat every three hours until symptoms are gone, up to 5 tablets per day. For best results, use for an additional 48 hours after symptoms subside. To avoid minor stomach upset, do n...
Drug Facts
Zincum Gluconicum 1X
Reduces duration and severity of the common cold
Stop use and ask a doctor if symptoms persist.
If pregnant or breast feeding, ask a health professional before use.
Keep out of reach of children.
For Adults and Children 12 years old and older:
Note: For maximum benefit, begin treatment at first sign of cold.
For Children under 12 years of age, consult a physician before use.
Copovidone, Crospovidone, Magnesium Stearate, Mannitol, Menthol, Mono-Ammonium Glycyrrhizinate, Natural and Artificial Flavors, Silicon Dioxide, Sodium Starch Glycolate, Sorbitol, Stearic Acid, Sucralose
Distributed by:
CVS Pharmacy, Inc.
One CVS Drive,
Woonsocket, RI 02895
CVS®
pharmacy
Compare to
the active ingredient
in Zicam® Rapid Melts®
Cold Remedy PLUS†
NEW!
COLD
REMEDY
PLUS
FAST MELTING
ZINC GLUCONICUM
Cool Mint
Homeopathic
Take at the first
sign of a cold
25
Quick dissolving
tablets

| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 64762-884-25 | 2019-11-13 | C162847 | 48780-1 | 97449f38-baec-f6ea-e053-dbdaa90aa703 | CVS ® pharmacy COLD REMEDY PLUS FAST MELTING |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 64762-884-25 | NBE Cool Mint Cold Remedy Fast Melting | 25 in 1 BOTTLE | LOZENGE | 25 | 1 | |
| 64762-884-25 | NBE Cool Mint Cold Remedy Fast Melting | 1 in 1 CARTON | LOZENGE | 1 | 1 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| ZINC GLUCONATE | ACTIVE INGREDIENT | U6WSN5SQ1Z | 1 | |
| ZINC | ACTIVE MOIETY | J41CSQ7QDS | 1 | |
| Ammonium Glycyrrhizate | INACTIVE INGREDIENT | 3VRD35U26C | 1 | |
| Copovidone K25-31 | INACTIVE INGREDIENT | D9C330MD8B | 1 | |
| Crospovidone | INACTIVE INGREDIENT | 68401960MK | 1 | |
| Magnesium Stearate | INACTIVE INGREDIENT | 70097M6I30 | 1 | |
| Mannitol | INACTIVE INGREDIENT | 3OWL53L36A | 1 | |
| Menthol | INACTIVE INGREDIENT | L7T10EIP3A | 1 | |
| Silicon Dioxide | INACTIVE INGREDIENT | ETJ7Z6XBU4 | 1 | |
| Sodium Starch Glycolate Type A Potato | INACTIVE INGREDIENT | 5856J3G2A2 | 1 | |
| Sorbitol | INACTIVE INGREDIENT | 506T60A25R | 1 | |
| Stearic Acid | INACTIVE INGREDIENT | 4ELV7Z65AP | 1 | |
| Sucralose | INACTIVE INGREDIENT | 96K6UQ3ZD4 | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 64762-884 | 64762-884-25 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| ZINC GLUCONATE | U6WSN5SQ1Z | ACTIB |
| Menthol | L7T10EIP3A | IACT |
| Copovidone K25-31 | D9C330MD8B | IACT |
| Crospovidone | 68401960MK | IACT |
| Magnesium Stearate | 70097M6I30 | IACT |
| Mannitol | 3OWL53L36A | IACT |
| Ammonium Glycyrrhizate | 3VRD35U26C | IACT |
| Silicon Dioxide | ETJ7Z6XBU4 | IACT |
| Sodium Starch Glycolate Type A Potato | 5856J3G2A2 | IACT |
| Sorbitol | 506T60A25R | IACT |
| Stearic Acid | 4ELV7Z65AP | IACT |
| Sucralose | 96K6UQ3ZD4 | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| Magnesium Stearate | MAGNESIUM STEARATE | 70097M6I30 | POWDER / ORAL | 25 mg | ||
| Mannitol | MANNITOL | 3OWL53L36A | LOZENGE / ORAL | 20546 mg | ||
| Sorbitol | SORBITOL | 506T60A25R | TABLET, DELAYED RELEASE / ORAL | 0.01 mg | ||
| Sucralose | SUCRALOSE | 96K6UQ3ZD4 | SUSPENSION, EXTENDED RELEASE / ORAL | 16 mg | ||
| Menthol | MENTHOL | L7T10EIP3A | MOUTHWASH / BUCCAL | 0.15 mg/1ml | ||
| Copovidone K25-31 | COPOVIDONE K25-31 | D9C330MD8B | SUSPENSION / ORAL | 172 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET / BUCCAL | 3 mg | ||
| Copovidone K25-31 | COPOVIDONE K25-31 | D9C330MD8B | CAPSULE, DELAYED RELEASE / ORAL | 199 mg | ||
| Sorbitol | SORBITOL | 506T60A25R | TABLET / SUBLINGUAL | 50.5 mg | ||
| Sucralose | SUCRALOSE | 96K6UQ3ZD4 | GUM, CHEWING / BUCCAL | 70 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | SUSPENSION, EXTENDED RELEASE / ORAL | 70 mg | ||
| Mannitol | MANNITOL | 3OWL53L36A | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL | 1568 mg | ||
| Sorbitol | SORBITOL | 506T60A25R | INJECTION / SUBCUTANEOUS | 4.7 %w/v | ||
| Mannitol | MANNITOL | 3OWL53L36A | INJECTION, SUSPENSION / INTRAMUSCULAR | 71 mg | ||
| Mannitol | MANNITOL | 3OWL53L36A | INJECTION, POWDER, FOR SUSPENSION / INTRAMUSCULAR | 164 mg | ||
| Sucralose | SUCRALOSE | 96K6UQ3ZD4 | TABLET, ORALLY DISINTEGRATING / ORAL | 60 mg | ||
| Mannitol | MANNITOL | 3OWL53L36A | SUSPENSION/ DROPS / OPHTHALMIC | 3.3 %w/v | ||
| Stearic Acid | STEARIC ACID | 4ELV7Z65AP | SHAMPOO / TOPICAL | 9.7 %w/w | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, COATED / ORAL | 176 mg | ||
| Mannitol | MANNITOL | 3OWL53L36A | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAMUSCULAR | 113 mg | ||
| Stearic Acid | STEARIC ACID | 4ELV7Z65AP | IMPLANT / SUBCUTANEOUS | 1.04 mg | ||
| Sorbitol | SORBITOL | 506T60A25R | SOLUTION, CONCENTRATE / ORAL | 300 mg/1ml | ||
| Sorbitol | SORBITOL | 506T60A25R | CONCENTRATE / ORAL | 600 mg/1ml | ||
| Sorbitol | SORBITOL | 506T60A25R | TABLET, COATED / ORAL | 12.96 mg | ||
| Sorbitol | SORBITOL | 506T60A25R | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS | 1.04 %w/v | ||
| Magnesium Stearate | MAGNESIUM STEARATE | 70097M6I30 | POWDER, FOR SUSPENSION / ORAL | 120 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | POWDER / ORAL | 602 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, FOR SUSPENSION / ORAL | 220 mg | ||
| Menthol | MENTHOL | L7T10EIP3A | POWDER, FOR SOLUTION / ORAL | NA | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | SYSTEM / TRANSDERMAL | 35 mg | ||
| Mannitol | MANNITOL | 3OWL53L36A | INJECTION, POWDER, FOR SOLUTION / SUBCUTANEOUS | 35 mg | ||
| Mannitol | MANNITOL | 3OWL53L36A | INJECTION, POWDER, FOR SUSPENSION / INTRAVENOUS | 181 mg | ||
| Magnesium Stearate | MAGNESIUM STEARATE | 70097M6I30 | TABLET / BUCCAL | 17.5 mg | ||
| Magnesium Stearate | MAGNESIUM STEARATE | 70097M6I30 | CAPSULE / ORAL | 256.4 mg | ||
| Sorbitol | SORBITOL | 506T60A25R | SOLUTION / NASAL | 25 mg/1ml | ||
| Magnesium Stearate | MAGNESIUM STEARATE | 70097M6I30 | TABLET, CHEWABLE, EXTENDED RELEASE / ORAL | 9 mg | ||
| Copovidone K25-31 | COPOVIDONE K25-31 | D9C330MD8B | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 53 mg | ||
| Magnesium Stearate | MAGNESIUM STEARATE | 70097M6I30 | DROPS / ORAL | NA | ||
| Mannitol | MANNITOL | 3OWL53L36A | SOLUTION / ORAL | 869 mg | ||
| Sucralose | SUCRALOSE | 96K6UQ3ZD4 | SYRUP / ORAL | 80 mg | ||
| Stearic Acid | STEARIC ACID | 4ELV7Z65AP | TABLET / ORAL | 336 mg | ||
| Mannitol | MANNITOL | 3OWL53L36A | TABLET / SUBLINGUAL | 495 mg | ||
| Menthol | MENTHOL | L7T10EIP3A | CAPSULE / ORAL | 0.87 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, DELAYED RELEASE / ORAL | 1190 mg | ||
| Sorbitol | SORBITOL | 506T60A25R | TABLET, ORALLY DISINTEGRATING / ORAL | 7 mg | ||
| Mannitol | MANNITOL | 3OWL53L36A | SOLUTION / TOPICAL | 4 %w/v | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | GEL / NASAL | 20 mg | ||
| Menthol | MENTHOL | L7T10EIP3A | SUSPENSION / ORAL | 1 mg | ||
| Mannitol | MANNITOL | 3OWL53L36A | CAPSULE, COATED, EXTENDED RELEASE / ORAL | NA | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 336 mg | ||
| Stearic Acid | STEARIC ACID | 4ELV7Z65AP | OINTMENT / TOPICAL | 15 %w/w | ||
| Sucralose | SUCRALOSE | 96K6UQ3ZD4 | TABLET, CHEWABLE / ORAL | 28 mg | ||
| Sorbitol | SORBITOL | 506T60A25R | CAPSULE / ORAL | 1111 mg | ||
| Sucralose | SUCRALOSE | 96K6UQ3ZD4 | TABLET, EFFERVESCENT / ORAL | 1080 mg | ||
| Copovidone K25-31 | COPOVIDONE K25-31 | D9C330MD8B | TABLET / SUBLINGUAL | 54 mg | ||
| Stearic Acid | STEARIC ACID | 4ELV7Z65AP | CREAM / TOPICAL | 190 mg | ||
| Menthol | MENTHOL | L7T10EIP3A | SOLUTION / ORAL | 3 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | POWDER, FOR SUSPENSION / ORAL | 2553 mg | ||
| Menthol | MENTHOL | L7T10EIP3A | TABLET / ORAL | 0.58 mg | ||
| Menthol | MENTHOL | L7T10EIP3A | GUM, CHEWING / BUCCAL | 89 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| f4acd8a0-fe19-4eed-800a-8f11363129c9 | 6b6a475b-0ce3-4b9b-af6b-1601388b3526 | 2011-08-24 | Warnings | f4acd8a0-fe19-4eed-800a-8f11363129c9 6b6a475b-0ce3-4b9b-af6b-1601388b3526 |
Adverse event summaries are temporarily unavailable. Other product information remains available.